학술논문
S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS.
Document Type
Article
Author
Sureda, Anna; Falchi, Lorenzo; Leppa, Sirpa; Vermaat, Joost; Holte, Harald; Hutchings, Martin; Lugtenburg, Pieternella; de Vos, Sven; Abrisqueta, Pau; Nijland, Marcel; Merryman, Reid W.; Christensen, Jacob Haaber; Wahlin, Bjorn; Linton, Kim; Wang, Liwei; Abbas, Aqeel; Rana, Ali; Quadri, Syed; Belada, David
Source
HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Subject
Language
ISSN
25729241